Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
0.00% $1.400
America/New_York / 24 apr 2024 @ 10:02
FUNDAMENTALS | |
---|---|
MarketCap: | 48.23 mill |
EPS: | -0.340 |
P/E: | -4.12 |
Earnings Date: | May 08, 2024 |
SharesOutstanding: | 34.45 mill |
Avg Daily Volume: | 0.0001 mill |
RATING 2024-04-24 |
---|
B+ |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Sell | |
Return On Asset: | Neutral | |
DE: | Strong Buy | |
P/E: | Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | n/a | |||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -4.12 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.13x |
Company: PE -4.12 | industry: PE 31.46 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 1.381 - 1.419 ( +/- 1.36%) |
ATR Model: 14 days |